UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

Haematologica (Roma), 2013-11, Vol.98 (11), p.1753-1761

2013

Volltextzugriff (PDF)

MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S358-S359

2017

Volltextzugriff (PDF)

Abstract 580: Effects of oral crofelemer on neratinib-induced diarrhea in beagle dogs

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.580-580

2020

Volltextzugriff (PDF)

Abstract P5-14-03: Effect of prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2-positive early-stage breast cancer: Phase II CONTROL trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-14-03

2020

Volltextzugriff (PDF)

Abstract PS13-20: Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS13-20-PS13-20

2021

Volltextzugriff (PDF)

Effect of prophylaxis on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer: Phase II CONTROL trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.548-548

2019

Volltextzugriff (PDF)

Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma

Blood, 2012-11, Vol.120 (21), p.4037-4037

2012

Volltextzugriff (PDF)

Abstract PO2-19-05: Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-19-05-PO2-19-05

2024

Volltextzugriff (PDF)

Hematologic safety data from four phase II studies of single-agent carfilzomib in relapsed and/or refractory multiple myeloma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8086-8086

2012

Volltextzugriff (PDF)

Summary of treatment-emergent renal events from patients treated with single-agent carfilzomib from four phase II studies in relapsed and/or refractory multiple myeloma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18569-e18569

2012

Volltextzugriff (PDF)

Integrated Safety From Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (MM): An Updated Analysis

Blood, 2011-11, Vol.118 (21), p.1876-1876

2011

Volltextzugriff (PDF)

Long-Term Treatment and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)

Blood, 2010-11, Vol.116 (21), p.1953-1953

2010

Volltextzugriff (PDF)

Pooled Safety Analysis From Phase (Ph) 1 and 2 Studies of Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (MM)

Blood, 2010-11, Vol.116 (21), p.1954-1954

2010

Volltextzugriff (PDF)

Banoxantrone (AQ4N), a Tissue Targeted Prodrug: Results of a Phase 1 Study in Lymphomas

Blood, 2006-11, Vol.108 (11), p.2429-2429

2006

Volltextzugriff (PDF)

Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates

The Journal of pediatrics, 1992-12, Vol.121 (6), p.980-983

1992

Volltextzugriff (PDF)

Penal power and border control: Which thesis? Sovereignty, governmentality, or the pre-emptive state?

Punishment & society, 2019-10, Vol.21 (4), p.496-514

2019

Volltextzugriff (PDF)

Digital Health Implementation Strategies Coproduced With Adults With Acquired Brain Injury, Their Close Others, and Clinicians: Mixed Methods Study With Collaborative Autoethnography and Network Analysis

Journal of medical Internet research, 2023-09, Vol.25 (10267), p.e46396

2023

Volltextzugriff (PDF)

Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial

JAMA internal medicine, 2015-06, Vol.175 (6), p.901

2015

Volltextzugriff (PDF)

Evaluating the strengths and challenges of PAX dream makers approach to mental health promotion: perspectives of youth and community members in indigenous communities in Manitoba, Canada

International journal of circumpolar health, 2022-12, Vol.81 (1), p.2089378-2089378

2022

Volltextzugriff (PDF)

Coproducing Knowledge of the Implementation of Complex Digital Health Interventions for Adults with Acquired Brain Injury and their Communication Partners: Protocol for a Mixed Methods Study

JMIR research protocols, 2022-01, Vol.11 (1), p.e35080-e35080

2022

Volltextzugriff (PDF)

Is PAX-Good Behaviour Game (PAX) Associated with Better Mental Health and Educational Outcomes for First Nations Children?

International journal of population data science, 2022-08, Vol.7 (3)

2022

Volltextzugriff (PDF)

Patient and carer experience of hospital-based rehabilitation from intensive care to hospital discharge: mixed methods process evaluation of the RECOVER randomised clinical trial

BMJ open, 2016-07, Vol.6 (8), p.e012041-e012041

2016

Volltextzugriff (PDF)

Police, crime and human rights

The Routledge International Handbook of Criminology and Human Rights, 2017, p.323-332

1, 2017

Volltextzugriff (PDF)

Policing a world in motion

Leanne Weber

2012

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(24)
Buchkapitel
(4)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study

Abstract 580: Effects of oral crofelemer on neratinib-induced diarrhea in beagle dogs

Abstract P5-14-03: Effect of prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2-positive early-stage breast cancer: Phase II CONTROL trial

Abstract PS13-20: Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Effect of prophylaxis on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer: Phase II CONTROL trial

Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma

Abstract PO2-19-05: Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)

Hematologic safety data from four phase II studies of single-agent carfilzomib in relapsed and/or refractory multiple myeloma

Summary of treatment-emergent renal events from patients treated with single-agent carfilzomib from four phase II studies in relapsed and/or refractory multiple myeloma

Integrated Safety From Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (MM): An Updated Analysis

Long-Term Treatment and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)

Pooled Safety Analysis From Phase (Ph) 1 and 2 Studies of Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (MM)

Banoxantrone (AQ4N), a Tissue Targeted Prodrug: Results of a Phase 1 Study in Lymphomas

Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates

Penal power and border control: Which thesis? Sovereignty, governmentality, or the pre-emptive state?

Digital Health Implementation Strategies Coproduced With Adults With Acquired Brain Injury, Their Close Others, and Clinicians: Mixed Methods Study With Collaborative Autoethnography and Network Analysis

Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial

Evaluating the strengths and challenges of PAX dream makers approach to mental health promotion: perspectives of youth and community members in indigenous communities in Manitoba, Canada

Coproducing Knowledge of the Implementation of Complex Digital Health Interventions for Adults with Acquired Brain Injury and their Communication Partners: Protocol for a Mixed Methods Study

Is PAX-Good Behaviour Game (PAX) Associated with Better Mental Health and Educational Outcomes for First Nations Children?

Patient and carer experience of hospital-based rehabilitation from intensive care to hospital discharge: mixed methods process evaluation of the RECOVER randomised clinical trial

Police, crime and human rights

Policing a world in motion

Suchergebnisse filtern